²é¿´: 103  |  »Ø¸´: 0

»ù´¡ÉúÎïʵÑéÍâ°

гæ (³õÈëÎÄ̳)

[½»Á÷] ÂöÂçĤÐÂÉúѪ¹Ü¶¯ÎïÄ£Ð͵Ĺ¹½¨

//
¶¯ÎïµÄÑ¡Ôñ


Ö÷ÒªÓÐÊó¡¢ÍúͺïµÈ¡£ÊóÊÇÄ¿Ç°ÓÕµ¼CNVÄ£ÐÍÓ¦ÓÃ×î¹ã·ºµÄʵÑ鶯Îï¡£

Êó

ÊóÓÕµ¼CNVµÄ·¢ÉúÂʽϸߣ¬´óÔ¼ÓÐ60£¥¡«70£¥ÔÚ¹âÄýºó¶Ìʱ¼ä£¨1ÖÜ£©ÄÚ¼´¿É²úÉú£¬¶øÇÒ¹âÄý°ßÓ«¹âÉø©10¡«14Ìì´ïµ½¸ß·å£¬±ãÓÚ½øÐиÉÔ¤ÐÔÑо¿£»ÓÕµ¼CNVµÄÌõ¼þÒ²¿É±ê×¼»¯£¬¼Û¸ñÏà¶Ô±ãÒË£¬±ãÓÚ»ùÒò²Ù×÷£¬¿ÉÓÃÓڹ۲쵥һ»ùÒò¹ý±í´ï»òµÍ±í´ï¶ÔCNVÉú³ÉµÄÓ°Ïì¡£

²»×ãÖ®´¦ÊÇFFAÖй۲쵽µÄÐÂÉúѪ¹ÜÉø©Âʵͣ¬½öΪ28£¥£¬ÇÒÊóµÄÑÛÇò½ÏС£¬²Ù×÷¼¼ÊõÒªÇó¸ß¡£´óÊóºÍСÊóCNVµÄÓÕ·¢ÂÊÎÞÃ÷ÏÔ²îÒ죬СÊóÑÛÇò¸üС£¬²Ù×÷ÒªÇó¸ü¸ß£¬¸üÊÊÓÚ½øÐÐÓйػùÒòÇóý·½ÃæµÄÑо¿¡£

ºï

ʵÑéÐÔºïCNVÄ£ÐÍÓëÈËÀ༲²¡¸Ä±ä¼«ÎªÏàËÆ£¬²»½ö×é֯ѧ¸Ä±äÒ»Ö£¬ÔÚÑÛµ×Ó«¹âËØѪ¹ÜÔìÓ°£¨FFA£©ÖÐÒ²¾ßÓÐÓ«¹âËØÉø©µÄÌØÕ÷¡£ÕâÖÖÐÂÉúѪ¹ÜÒ»°ã·¢ÉúÔÚ¼¤¹â¹âÄýºó4ÖÜ£¬¿É³ÖÐø2¡«52ÖÜ¡£ÔöÉúÒÆÐеÄRPEϸ°û°üÈÆÐÂÉúѪ¹Üºó£¬ÐÂÉúѪ¹ÜÓ«¹âËØÉø©µÄ±íÏÖ»áÔ½À´Ô½²»Ã÷ÏÔ¡£

¾¡¹ÜÕâÖÖÄ£Ð͵õ½ÁËÒ»ÖµÄÈÏ¿É£¬µ«¶¯ÎïÀ´Ô´ÊÜÏÞ£¬·ÑÓýϸߣ¬CNVÓÕ·¢Ê±¼ä½Ï³¤£¬·¢ÉúÂʵͣ¬ÏÞÖÆÁËÆäÓ¦Óá£

ÍÃ

ÍòúÉúµÄCNVÔÚFFAÖв»¾ßÓÐÓ«¹âËØÉø©µÄÌØÕ÷£¬¼ÓÖ®¿¼Âǵ½ÍõÄÑÛµ×Ѫѭ»·½á¹¹ÓëÈËÀàÓнϴóµÄ²îÒ죬ĿǰÒÑ»ù±¾²»ÓÃÍÃ×ö´ËÀàÄ£ÐÍ¡£

//
ÔìÄ£·½·¨


Ò»
¼¤¹âÓÕµ¼¶¯ÎïÄ£ÐÍ

ÔìÄ£·½·¨£º

½¡¿µ×ØɫŲÍþ´óÊó£¬ÐÛÐÔ£¬ÌåÖÊÁ¿180-200g£¬10%Ë®ºÏÂÈÈ©(0.35mL/100gÌåÖÊÁ¿)¸¹Ç»×¢ÉäÂé×í¡£¸´·½ÍÐßÁ¿¨°·µÎÑÛÒºµãÑÛɢͫ¡£ÑÛÇ°·ÅÖõμÓÉÙÁ¿ 1%¼×»ùÏËάËصĸDz£Æ¬½Ó´¥½ÇĤ£¬ë´¼¤¹â(²¨³¤647nm£¬¹â°ßÖ±¾¶50um£¬¹¦ÂÊ360mW£¬Æعâʱ¼ä0.05s)¾àÊÓÅÌ2~3¸öÊÓÅÌÖ±¾¶¾ùÔȹâÄý9¸öµã£¬ÒÔ¼ûµ½ÓÐÆøÅݲúÉúÌáʾBruchĤ±»»÷´©Îª×¼¡£



FFAµÄ¹Û²ì£º

¹âÄýºóµÚ3¡¢7¡¢14¡¢21¡¢30dËæ»úÑ¡È¡4Ö»´óÊóÐÐFFA¼ì²é¡£É¢Í«¼°Âé×í·½·¨Í¬Ç°£¬10%Ó«¹âËØÄÆ×¢ÉäÒº0.5mL/kg¸¹Ç»×¢ÉäºóÁ¢¼´ÐÐFFA¡£FFAͼÏñ·ûºÏÒÔÏÂÌص㼴ÈÏΪCNVÐγɣ¬¢ÙÔÚÔìÓ°ÔçÆÚ¼´¶¯ÂöÇ°ÆÚ»ò¶¯ÂöÆÚ¼´ÏÔÓ°¡£¢ÚÓëÊÓÍøĤѪ¹ÜϵͳûÓÐÁªÏµ¡£¢ÛÓ«¹âËØѸËÙÉø©£¬ÓÐÒ»¶¨µÄ»ý´æ·¶Î§£¬ºóÆÚÐγɸßÓ«¹âÇø¡£½«¸÷ʱ¼ä¶Î³öÏÖCNV¹âÄý°ßÊýÄ¿Óë¸Ãʱ¼ä¶ÎµÄ¹âÄý°ß×ÜÊýµÄ±ÈÖµ×÷Ϊ¸Ãʱ¶ÎµÄCNV·¢ÉúÂÊ¡£

ºóÐø½øÐй⾵¹Û²ì¡¢×éÖ¯²¡ÀíѧCNVÏà¶Ôºñ¶È²âÁ¿¡¢Í¸Éäµç¾µ¹Û²ì¡£



Óŵ㣺

¼¤¹âÓÕµ¼µÄCNV¶¯ÎïÄ£ÐÍ·¢ÉúÂʽϸߣ¬´óԼΪ 60%~70%£¬ÔÚ¹âÄýºó¶ÌÆÚʱ¼ä£¨7d£©ÄÚ¼´¿É²úÉú£¬¶øÇÒ¼¤¹â°ßµÄÓ«¹âËØÉø©ÔÚ 10~14d´ïµ½¸ß·å£¬±ãÓÚ½øÐиÉÔ¤ÐÔÑо¿£»ÓÕµ¼CNVµÄÌõ¼þÒ²¿É±ê×¼»¯£¬¼Û¸ñÏà¶Ô±ãÒË£¬ÊÇÄ¿Ç°ÑÛ¿ÆÓÕµ¼CNV×î³£ÓõĶ¯ÎïÄ£ÐÍ¡£



¶þ
Éú³¤Òò×ÓÓÕµ¼CNVÄ£ÐÍ

°üÀ¨ÊÓÍøĤÏÂ×¢ÉäÔØÓÐѪ¹ÜÄÚƤÉú³¤Òò×Ó£¨vascular endothelial growth factor£¬VEGF£©»ùÒòµÄÏÙÏà¹Ø²¡¶¾ÔØÌå¡¢ÖØ×éVEGFÃ÷½ºÎ¢Á£ÓÕµ¼CNVÄ£ÐÍ¡¢ÊÓÍøĤÏÂ×¢Éä¼îÐÔ³ÉÏËάϸ°ûÉú³¤Òò×Ó£¨basic fibroblastgrowth factor£¬bFGF£©Äý½ºÎ¢Á£ÓÕµ¼ÍÃCNVÄ£ÐÍ¡¢ÊÓÍøĤÏÂ×¢ÉäbFGF/Ö¬¶àÌÇÓÕµ¼ÍÃCNVÄ£ÐÍ¡¢ÂöÂçĤÉÏǻֲÈëbFGF΢Éø͸±ÃÓÕµ¼ÖíCNVÄ£Ð͵ȡ£ÆäÖÐÊÓÍøĤÏÂ×¢ÉäÔØÓÐVEGF»ùÒòµÄÏÙÏà¹Ø²¡¶¾£¨adeno-associated virus£¬AAV£©ÔØÌåÓÕµ¼CNVÄ£ÐÍÊǽÏΪÀíÏëµÄÄ£ÐÍ¡£



ÔìÄ£·½·¨1£º

½«2¦Ìl±àÂëÈË VEGF-A165ÏÙ²¡¶¾×¢Éäµ½´óÊóÊÓÍøĤÏ£¬CNV·¢ÉúÂÊΪ95%¡£



ÔìÄ£·½·¨2£º

ÔÚÍÃÑÛÊÓÍøĤÏÂ×¢Éä5¡Á106IUÔØÓйý±í´ïVEGF-A165ÏÙ²¡¶¾ÔØÌåÓÕµ¼CNVÄ£ÐÍ£¬CNV·¢ÉúÂÊΪ83%¡£



Èý
ת»ùÒò»ò»ùÒòÇóýÓÕµ¼

ת»ùÒòºÍ»ùÒòÇóý½¨Á¢CNVÄ£ÐÍÊÇÒ»ÖÖÐÂÐ˼¼Êõ£¬Õë¶ÔCNV·¢Õ¹µÄ¹Ø¼üÒòËؽ¨Á¢»ùÒò¹¤³ÌÄ£ÐÍ£¬¿É´Ó²»Í¬½Ç¶È·ÖÎö¸÷·Ö×Ó¶ÔCNVÐγɵÄÓ°Ï죬°üÀ¨£º£¨1£©VEGF164RPE65ת»ùÒòСÊ󣻣¨2£©Ë«±¶Ì壨Tet/VMD2/VEGF£©ºÍÈý±¶Ì壨Tet/VMD2/VEGF/An2£©×ª»ùÒòСÊó£¬ÊÓÍøĤ¿É¸ß±í´ïVEGF£¬ÈôͬʱÊÓÍøĤÏÂ×¢ÉäѪ¹ÜÉú³ÉËØ2£¨angiogenin2£¬Ang2£©£¬Äܹ»100%ÐγÉCNV£»£¨3£©Ç÷»¯Òò×ÓCCÀàÊÜÌå2£¨chemokine CC motif receptor 2£¬CCR2£©/Ç÷»¯Òò×ÓCCÀàÅäÌå2£¨chemokine CC motif ligand 2£¬CCL2£©»ùÒòȱʧÓÕµ¼Ð¡ÊóCNVÄ£ÐÍ£¬Æä³ÉÄ£ÂÊ´óÔ¼25£¥£»£¨4£©ÔØÖ¬µ°°×E»ùÒò£¨apolipoprotein E£¬ApoE£©¹ý±í´ïСÊóCNVÄ£ÐÍÊÇÑо¿AMD²¡±äÖÐ×Ô·¢ÐÔCNVÐγɻúÖƵÄÖØҪģÐÍ£»£¨5£©CCL2ºÍCX3CÇ÷»¯Òò×ÓÊÜÌå1£¨CX3C chemokine receptor 1£¬CX3CR1£©»ùÒòȱÏÝСÊ󣻣¨6£©³¬Ñõ»¯ÎïÆ绯ø1£¨superoxide dismutase 1£¬SOD1£©»ùÒòȱÏÝÀÏ»¯Ð¡Ê󣻣¨7£©¼«µÍÃܶÈÖ¬µ°°×ÊÜÌ壨very low density lipoprotein receptor£¬VLDLR£©¶¨ÏòÍ»±äСÊ󣻣¨8£©ÊÓ×ϺìÖÊ»ùÒòÆô¶¯×Ó/VEGF¹ý±í´ïСÊó¡£


ÓÅȱµã£º

ת»ùÒò»ò»ùÒòÇóýÓÕµ¼µÄCNVÄ£Ð;ßÓÐÓÕµ¼¿ì£¬·¢Éúʱ¼ä¶ÌµÈÓŵ㣬ÓëCNV²¡ÀíÉúÀíѧ¹ØÁªÐÔÇ¿£¬¶ÔCNV·¢Éú»úÖƵÄÑо¿¾ßÓÐÕë¶ÔÐÔ£¬Í¬Ê±Ñо¿Õ߿ɸù¾Ý²»Í¬ÐèÇóÑ¡ÔñÄ£ÐͲ¢Ð޸IJÎÊý£»È±µãÓÐCNVÓÕµ¼Âʵ͡¢Ãæ»ýС¡¢¼Û¸ñ¹óµÈÎÊÌâ¡£

//
×ܽá


ÔÚÖڶཨÁ¢CNVÄ£Ð͵ķ½·¨ÖУ¬¼¤¹âÓÕµ¼CNVÄ£ÐÍÌõ¼þ½Ï³ÉÊ죬Ñо¿ÀúÊ·¾Ã£¬¿É¿¿ÐԸߣ¬Ó¦Óù㷺¡£ÓÉÓÚ¶¯ÎïÌåÄÚ»·¾³²»Í¬ÓÚÈËÌåÄÚ»·¾³£¬¸÷ÖÖ·½·¨ÓÕµ¼µÄCNV¶¯ÎïÄ£ÐÍÒ²½öÄÜÄ£ÄâÈËÀàCNV£¬²»ÄÜÍêÈ«´úÌæÈËÀàCNV·¢Õ¹µÄ×ÔÈ»¹ý³Ì£¬Òò´Ë£¬Ñо¿½á¹û½öÄÜΪCNV·¢²¡ºÍ»úÖÆÑо¿ÌṩʵÑéÀíÂÛÒÀ¾Ý¡£
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌøת ÎÒÒª¶©ÔÄÂ¥Ö÷ »ù´¡ÉúÎïʵÑéÍâ° µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍƼö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[»ù½ðÉêÇë] »ù½ðίҲÊÇ´ò¹¤µÄ +24 wsjing 2024-05-16 32/1600 2024-05-20 11:29 by dd921ww
[½Ìʦ֮¼Ò] ½ñÌì²ÅÖªµÀ˶ʿ¿¼½ø´óר±È²©Ê¿½ø±¾¿Æ¹¤×ʸߵöà +9 ZHONGWU_U 2024-05-14 11/550 2024-05-20 11:24 by ÉÙÄêÌ«ÃÀ
[¿¼²©] ¡¾2025 É격¡¿²ÄÁÏ»òÕßÒ±½ð¹¤³Ì +4 ·ãÂä¹Â³Ç 2024-05-19 5/250 2024-05-20 10:52 by ·ãÂä¹Â³Ç
[Óлú½»Á÷] ³ýDMSO +4 Spiralup 2024-05-15 5/250 2024-05-20 10:21 by 88817753
[½Ìʦ֮¼Ò] ÓÅÐã±ÏÒµÂÛÎÄ Ö¸µ¼½Ìʦ£¬ÆÕͨÀÏʦÓÐÏ£ÍûÂ𣿠+6 ºÓÎ÷Ò¹ÀÉ 2024-05-17 7/350 2024-05-20 09:36 by ÏþÄ¿³ç
[»ù½ðÉêÇë] È¥ÄêÉêÇë»ù½ðµÄÆÀÉóÒâ¼ûÊÇChatGPTÔÚ¹úÄÚÊǽûÖ¹µÄ£¬Ñо¿·½°¸ÖÐÓÐʹÓÃChatGPT²»ºÏÀí +3 ˲ϢÓîÖæ 2024-05-19 3/150 2024-05-20 09:30 by jurkat.1640
[»ù½ðÉêÇë] ÉêÇë»ù½ð´ú±íÐԳɹû +13 lancet0903 2024-05-17 14/700 2024-05-19 22:35 by ÊÖÐÄÀïµÄÐÒ¸£
[¿¼²©] ¿¼²©¿çרҵ¿ÉÒÔ¿ç¶àÔ¶ +5 ÖñÍâ¡£¡£¡£ 2024-05-18 6/300 2024-05-19 21:51 by ĦÌì˼Èð
[˶²©¼ÒÔ°] º£Íⲩʿ£¬¹úÄÚ²©ºóÕÒ¹¤×÷Çó½¨Òé +8 905452934 2024-05-16 19/950 2024-05-19 17:56 by ËýÔÚѧϰ
[ÕÒ¹¤×÷] Õã½­µÄ¸ßУÏÖÔÚÃż÷¶¼Õâô¸ßÂð +10 dadqweq_qw 2024-05-16 10/500 2024-05-19 17:02 by wenwen0825
[ÂÛÎÄͶ¸å] ÍƼöתͶ£¨ transfer pending£©ÊÇ·ñÓÐÓã¿ 50+3 lily5289 2024-05-17 7/350 2024-05-19 15:11 by wanghuawei
[ÂÛÎÄͶ¸å] ÇóÍƼöÆÚ¿¯ 20+3 ºÃÀ§ºÃÀ§a 2024-05-18 4/200 2024-05-19 11:30 by nono2009
[»ù½ðÉêÇë] ´óÀÐÃÇ£¬ÄÄλ´óÉñÖªµÀE09ÓÐûÓÐËÍ°¡£¿ +4 Å£×ØÉ«×óÓÒ 2024-05-15 7/350 2024-05-18 22:48 by Å£×ØÉ«×óÓÒ
[½Ìʦ֮¼Ò] °×Ìì²»¶®Ò¹µÄºÚ£¬90ºóÇཷÓë60ºóÀÏ°å +3 zylfront 2024-05-18 4/200 2024-05-18 10:12 by zylfront
[ÁôѧDIY] ÇóÖú£ºÒ½ÉúÏëÈó +7 safrina 2024-05-15 7/350 2024-05-17 18:50 by ¿¨Æ¤°ÉÀ²123
[µç»¯Ñ§] ï®Àë×Óµç³Øʯī¸º¼«Óà 1M LiPF6 in DEC:EC=1:1 Vol% ¿ÉÒÔÂ𣿠50+3 fffhhhhh 2024-05-15 8/400 2024-05-17 14:57 by ¶àµã¹ØÐĶàµãi
[Óлú½»Á÷] ÎÞË®ÁòËáÄƳýË® 80+3 ÌÒÌÒPXS 2024-05-13 5/250 2024-05-17 09:49 by FuMmm
[¿¼²©] Ñ°ÕҸ߷Ö×ÓÁìÓò²©µ¼ +8 СÕþÑÅͼ 2024-05-14 11/550 2024-05-16 22:10 by µ¥µ÷µÄÅÖ×Ó
[»ù½ðÉêÇë] ϵͳµ¼³öÉ걨ÊéÖвÎÓëÈËÄÇÒ»Ò³µÄ¸ñʽ£¬¿çÈëÁ½Ò³£¬ÒªÍ¨¹ýµ÷ÕûÐмä¾àµ÷Õûµ½Ò»Ò³Â𣿠+3 danisha 2024-05-15 5/250 2024-05-16 18:21 by danisha
[»ù½ðÉêÇë] ÇàÄê°Î¼â³ö¯ +5 babu2015 2024-05-14 6/300 2024-05-15 21:27 by msjy
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û